Trial intelligence / Profile preview

HCG vs LH Surge for IUI Timing

NCT02638285Phase 4Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jan 2009
Primary completion
Aug 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of human chorionic gonadotropin in infertility (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pregnancy Rate at 2 weeks. Started Jan 2009; status: completed.

02

Drugs

human chorionic gonadotropin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT02638285.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02638285.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call